(Q32173605)

6 July 2017

title

Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia (English)

1 reference

6 July 2017

4

Hochhaus A

1 reference

6 July 2017

Krämer A

1

1 reference

6 July 2017

Löffler H

series ordinal

2

1 reference

6 July 2017

Bergmann J

series ordinal

3

1 reference

6 July 2017

Hehlmann R

series ordinal

5

1 reference

6 July 2017

publication date

1 January 2001

1 reference

6 July 2017

1 reference

6 July 2017

volume

15

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

62-68

1 reference

Clonal origin of chronic myelocytic leukemia in man

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Characterization of CD34+ human hemopoietic progenitor cells from the peripheral blood: enzyme-, carbohydrate- and immunocytochemistry, morphometry, and ultrastructure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

An in vivo study on the synchronizing effect of hydroxyurea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402005

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402005

1 reference

Dimensions Publication ID

6 July 2017

1025748506

0 references

1 reference